These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30578782)

  • 1. Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.
    Ferrer-Torres D; Nancarrow DJ; Steinberg H; Wang Z; Kuick R; Weh KM; Mills RE; Ray D; Ray P; Lin J; Chang AC; Reddy RM; Orringer MB; Canto MI; Shaheen NJ; Kresty LA; Chak A; Wang TD; Rubenstein JH; Beer DG
    Gastroenterology; 2019 Apr; 156(5):1404-1415. PubMed ID: 30578782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proanthocyanidins mitigate bile acid-induced changes in GSTT2 levels in a panel of racially diverse patient-derived primary esophageal cell cultures.
    Weh KM; Turgeon DK; Rubenstein JH; Clarke JL; Howell AB; Chang AC; Kresty LA
    Mol Carcinog; 2022 Mar; 61(3):281-287. PubMed ID: 34758158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
    Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
    Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.
    Peng DF; Razvi M; Chen H; Washington K; Roessner A; Schneider-Stock R; El-Rifai W
    Gut; 2009 Jan; 58(1):5-15. PubMed ID: 18664505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
    J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.
    Kunze B; Wein F; Fang HY; Anand A; Baumeister T; Strangmann J; Gerland S; Ingermann J; Münch NS; Wiethaler M; Sahm V; Hidalgo-Sastre A; Lange S; Lightdale CJ; Bokhari A; Falk GW; Friedman RA; Ginsberg GG; Iyer PG; Jin Z; Nakagawa H; Shawber CJ; Nguyen T; Raab WJ; Dalerba P; Rustgi AK; Sepulveda AR; Wang KK; Schmid RM; Wang TC; Abrams JA; Quante M
    Gastroenterology; 2020 Aug; 159(2):575-590. PubMed ID: 32325086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
    Sun X; Chandar AK; Canto MI; Thota PN; Brock M; Shaheen NJ; Beer DG; Wang JS; Falk GW; Iyer PG; Abrams JA; Venkat-Ramani M; Veigl M; Miron A; Willis J; Patil DT; Nalbantoglu I; Guda K; Markowitz SD; Zhu X; Elston R; Chak A
    PLoS One; 2017; 12(10):e0184962. PubMed ID: 29073141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.
    Thota PN; Zackria S; Sanaka MR; Patil D; Goldblum J; Lopez R; Chak A
    J Clin Gastroenterol; 2017; 51(5):402-406. PubMed ID: 27306940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
    Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC
    Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions.
    Phipps SM; Garry CE; Kamal S; Johnson JD; Gilmer J; Long A; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):601-622. PubMed ID: 32416156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.
    Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL
    PLoS One; 2015; 10(6):e0128617. PubMed ID: 26039359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of glutathione S-transferase-Pi expression at mRNA levels in oesophageal mucosa using RT-PCR-ELISA in individuals with reflux diseases, adenocarcinoma and squamous cell carcinoma.
    Rasmi Y; Allameh A; Nasseri-Moghaddam S; Gill P; Moghaddam MF; Hedayati M
    Clin Biochem; 2006 Oct; 39(10):997-1001. PubMed ID: 16979613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.
    Kuramochi H; Vallböhmer D; Uchida K; Schneider S; Hamoui N; Shimizu D; Chandrasoma PT; DeMeester TR; Danenberg KD; Danenberg PV; Peters JH
    J Gastrointest Surg; 2004 Dec; 8(8):1007-16; discussion 1016-7. PubMed ID: 15585388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From GERD to Barrett's esophagus: is the pattern in Asia mirroring that in the West?
    Ho KY
    J Gastroenterol Hepatol; 2011 May; 26(5):816-24. PubMed ID: 21265879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.